Publication & Citation Trends
Most Cited Works
Publications
357 total
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer—Results of the prospective multicenter PERMAD trial OA
Cited by 2
Semantic Scholar
mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) OA
Cited by 1
Semantic Scholar
Organ preservation with durvalumab-based immunotherapy in combination with chemoradiation as definitive therapy for early stage, cT1, and cT2N0 esophageal adenocarcinoma with indication for radical surgery: A prospective, multicenter study of the FLOT-AIO Gastric Cancer Group (IKF-t057/PRESTO trial)
Cited by 1
Semantic Scholar
Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy
Cited by 3
Semantic Scholar
A novel biomarker combination and its association with resistance to chemotherapy combinations with bevacizumab: First results of the PERMAD trial. OA
Cited by 0
Semantic Scholar
Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses PDF
Cited by 184
OpenAlex
Economic outcomes of sequences which include monoclonal antibodies against vascular endothelial growth factor and/or epidermal growth factor receptor for the treatment of unresectable metastatic colorectal cancer OA
Cited by 7
Semantic Scholar
Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group.
Cited by 69
Semantic Scholar
Research Topics
Virus-based gene therapy research
(68)
Colorectal Cancer Treatments and Studies
(63)
Gastric Cancer Management and Outcomes
(40)
Hepatocellular Carcinoma Treatment and Prognosis
(39)
Cancer Research and Treatments
(36)
Frequent Co-Authors
Affiliations
Semmelweis University
Huaqiao University
University of Iowa
NHS Blood and Transplant
The University of Texas MD Anderson Cancer Center